🔗 Permalink

Inventor profile of:

Serge Picaud

City:

Paris

Country:

France

Published Applications:

Last publication date:

2024-03-21

Top Assignees for applications by Serge Picaud

The entities that hold a legal rights for patent applications filed by inventor Picaud Serge:

SORBONNE UNIVERSITE 3 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 2 PARIS, France
Essilor International 1 Charenton-le-Pont, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 1 Paris, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris, France
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) 1 Paris Cedex 13, France
ECOLE SUPERIEURE DE PHYSIQUE ET DE CHIMIE INDUSTRIELLES DE LA VILLE DE PARIS 1 Paris, France
SORBONNE UNIVERSITE 1 Paris, Greece

Recent patent applications by Picaud Serge

Serge Picaud from Paris, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-03-21

US20240092858A1

Chemistry; metallurgy

TREATMENT OF CONGENITAL STATIONARY NIGHT BLINDNESS USING GENE THERAPY

#2 | 2023-10-19

US20230330440A1

Human necessities

DEVICES AND METHODS BASED ON ULTRASOUNDS FOR RESTORING VISION OR ANY OTHER BRAIN FUNCTION

#3 | 2022-06-16

US20220187627A1

Physics

Filter for eye cone cells protection

#4 | 2021-10-07

US20210308169A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#5 | 2016-07-28

US20160213701A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#6 | 2016-07-21

US20160206579A1

Human necessities

TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION

#7 | 2015-02-05

US20150038557A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES

#8 | 2012-06-21

US20120157532A1

Human necessities

Method Of Treating Or Preventing A Convulsive Disorder In A Patient In Need Thereof

#9 | 2012-02-02

US20120027723A1

Human necessities

TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION AND TREATMENT OF A DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEGENERATION

#10 | 2011-07-28

US20110183890A1

Human necessities

Methods for modulating angiogenesis via dystrophin Dp71

#11 | 2011-07-14

US20110172171A1

Human necessities

TAURINE OR TAURINE-LIKE SUBSTANCES FOR THE PREVENTION OF BRAIN OEDEMA

InventorID:

1059664 ⎘